AnorMED, Inc.

Hematology-focused company closes offering for proceeds of $34,500,000

Published in Healthcare Mergers, Acquisitions and Ventures Week, January 14th, 2006

AnorMED, Inc., (AOM; AOM) has successfully closed its offering of 8,625,000 common shares for gross proceeds of $34,500,000 in connection with the previously announced agreement with an underwriting syndicate co-led by Raymond James, Ltd., and BMO Nesbitt Burns, Inc., and including CIBC World Markets, Inc., and Canaccord Capital Corp.

The underwriting syndicate agreed to purchase 6,250,000 common shares from AnorMED, on a bought deal basis, and sell to the public at a price of $4.00 per common share, representing an aggregate issue amount of $25,000,000.

As well, the underwriters have exercised their option under the underwriting agreement to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2006-01-14)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Accelr8 Technology Corp.
Medical instrumentation maker reports loss of $0.08 per share
Adams Respiratory Therapeutics, Inc.
Respiratory disorders-focused company prices secondary offering
American Oriental Bioengineering, Inc.
Chinese pharmaceutical firm reports options to trade on Chicago Board Options Exchange
Amgen
Biotech company to acquire Abgenix for $22.50 per share
AnorMED, Inc.
Hematology-focused biotech company obtains receipts for short-form prospectus
Antigenics, Inc.
Bruce A. Leicher joins company developing patient-specific immunotherapies as general counsel
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry